Enterome’s shareholder, SEVENTURE PARTNERS, announced the launch of its new fund.

The new management of SEVENTURE PARTNERS drives a group of Industry and Finance Leaders in the launch of a 120 M€ innovation fund HEALTH FOR LIFE CAPITAL. One of the major Enterome’s shareholder, SEVENTURE PARTNERS, announced the launch of its new fund: Health for Life Capital. This €120m fund is dedicated to health, connected health, nutrition, and the recent game-changing discoveries related to the microbiome. The fund will invest in innovative companies with high growth potential mainly in Europe but also in North America and Asia. Seventure’s team has built a unique portfolio of companies operating in the microbiome and nutrition fields such as Enterome, LNC, Polaris, Nutrionix, Fluxome (sold to Evolva) and others related to connected health such as Mauna Kea, Cardiosecure-PMS, Acarix, Impeto, Biancamed (sold to Resmed).